| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |